Project Details
Description
NBI-74788-CAH2001: A Phase 2, Open-Label, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 in Adult Subjects with Congenital Adrenal Hyperplasia
| Status | Finished |
|---|---|
| Effective start/end date | 4/1/18 → 4/30/22 |
Funding
- NEUROCRINE BIOSCIENCES, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.